科研论文 及著作 |
1. Liang S, Zhang D, Qi J, et al. Reduced peak stimulated growth hormone is associated with hyperuricemia in obese children and adolescents. Scientific Reports , 2018, 8(1):7931. 2. Liang S, Xue J, Li G. Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency. Lipids in Health & Disease, 2018, 17(1):66. 3. Liang S, Yu Z, Song X, et al. Reduced Growth Hormone Secretion is Associated with Nonalcoholic Fatty Liver Disease in Obese Children. Hormone & Metabolic Research, 2018, 50(3). 4. Liang S, Cheng X, Hu Y, Li G*,et al. Insulin like growth factor 1 and metabolic parameters are associated with non-alcoholic fatty liver disease in obese children and adolescents. Acta Paediatrica, 2017, 106(2):298-303 5. Liang S, Hu Y, Liu C, Li G*, et al. Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study. Lipids in Health & Disease, 2016, 15(1):1-7. 6. Wu J, Zhao F, Zhang Y, Xue J, Kuang J, Jin Z, Zhang T, Jiang C, Wang D, Liang S*. Effect of One-Year Growth Hormone Therapy on Cardiometabolic Risk Factors in Boys with Obesity. Biomed Res Int, 2020:2308124. IF:2.885 7. Kuang J, Zhang L, Xu Y, Xue J, Liang S, Xiao J. Reduced Insulin-Like Growth Factor 1 Is Associated with Insulin Resistance in Obese Prepubertal Boys. Biomed Res Int. 2021:6680316 8. Liang S, Niu W, Wang H, Yang L. Alterations of Ocular Surface Parameters in Type 2 Diabetic Patients. Diabetes Metab Syndr Obes. 2021 28;14:3787-3793 9. Xue J, Liang S, Ma J, Xiao Y. Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease. BMC Endocr Disord. 2022 26;22(1):49. 10.牛婉侠,梁爽,王一彪.儿童肥胖相关心肌病的分子机制[J].中国儿童保健杂志,2023,31(05):507-511. |
